Physician

Daniel Yip, MD

According to 2025 Medicare claims, Daniel Yip, MD (NPI: 1699762856) practices advanced heart failure and transplant cardiology in the Jacksonville, FL market, with the plurality of this provider's patient population coming from Duval, FL. This provider's primary affiliated billing organization is MAYO CLINIC JACKSONVILLE (NPI: 1790772317; TIN: 593337028) and primary practice location at 32224-1865. Yip is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Yip's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 195 traditional Medicare patients, billed 982 HCPCS/CPT codes, and received $83,507 in Medicare payments. The top billing code was 93505 (Biopsy of heart muscle). Part D data shows 933 prescription claims across 158 beneficiaries totaling $155,535 in drug costs, led by Entresto (Sacubitril/Valsartan). DME data shows 322 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $130,979 to $155,535. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $21,918 and ending at $9,641.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	203	949	$80,296
2016	192	1,510	$122,518
2017	182	1,376	$110,885
2018	172	1,227	$103,819
2019	186	996	$79,537
2020	217	1,304	$94,995
2021	240	1,298	$107,140
2022	221	963	$90,414
2023	209	857	$76,381
2024	195	982	$83,507

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	189	1,937	$130,979
2016	184	2,021	$123,508
2017	188	1,659	$132,063
2018	192	1,690	$149,862
2019	191	1,584	$145,072
2020	225	1,889	$202,037
2021	255	2,150	$222,954
2022	225	1,636	$242,156
2023	189	1,161	$197,497
2024	158	933	$155,535

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	132	813	$133,001
2016	134	778	$85,437
2017	126	641	$44,035
2018	124	862	$69,270
2019	109	643	$84,910
2020	170	1,177	$66,496
2021	167	1,021	$45,025
2022	154	689	$22,375
2023	126	700	$19,551
2024	71	322	$6,625

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93505	Biopsy of heart muscle	23	34	$166
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	28	30	$134
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	27	29	$132
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	48	324	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	127	240	$86

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	50	2,640	$57,152
Eliquis	Apixaban	47	1,897	$35,351
Farxiga	Dapagliflozin Propanediol	15	1,057	$17,805
Jardiance	Empagliflozin	14	610	$8,167
Metoprolol Succinate	Metoprolol Succinate	98	6,855	$2,015

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	18	66	$1,626
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	29	106	$1,329
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	67	$1,264
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	24	70	$1,223
J7515	Cyclosporine, oral, 25 mg	N	N/R	13	$1,183

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Daniel Yip, MD?

Tedicare shows public-source Medicare data for Daniel Yip, MD (NPI 1699762856), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Yip, MD have ACO affiliation data?

Daniel Yip, MD is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Daniel Yip, MD?

Daniel Yip, MD is linked to MAYO CLINIC JACKSONVILLE (billing NPI 1790772317) in the available physician profile data.

Does Daniel Yip, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.